The awakening:GABA-A receptors as targets for improving motor function [ 2017 - 2019 ]

Research Grant

Researchers: Prof Mary Collins Chebib (Principal investigator) ,  A/Pr Thomas Balle ,  Dr Andrew Clarkson

Brief description Zolpidem (Stilnox) is a “sleeping pill” that is reported "awaken" people with severe motor, memory and speech disabilities that result from stroke or other brain injury. We have identified a novel target by which zolpidem can exert these effects. This project will characterise this target and assess drug effects in models of stroke.

Funding Amount $AUD 752,307.66

Funding Scheme Project Grants

Notes Standard Project Grant